Is there something interfering with your drug delivery?

Not all indications may be available in all territories.

Enter

The Gold-Standard

The gold-standard Drug-Eluting Bead, DC Bead™ is supported by ten years' experience and more than 100 publications in over 6,000 HCC patients.2

Not all indications may be available in all territories.

Learn More

Experience

The benefits of DC Bead are supported by over 150 peer reviewed papers and are now recognised in the European Clinical Practice Guidelines for HCC4,5


Survival Data

DC Bead is challenging survival expectations for intermediate HCC patients2, 3


History

Launched in 2005 DC Bead is the leading drug eluting bead that has been used to treat patients requiring transarterial chemoembolisation (TACE) in malignant hypervascularised tumour(s) and malignant colorectal cancer metastasised in the liver


DC Bead

 

The gold-standard Drug-Eluting Bead, DC Bead™ is supported by ten years' experience and more than 80 publications reporting outcomes in over 3000 HCC patients.2